EPISODE · May 4, 2026 · 1 MIN
Tilray's Rescheduling Hopes Dampened
from The Daily News Now! Business
Tilray Brands stock surged on April 22nd due to the Justice Departments potential marijuana rescheduling, but the rally faded as investors realized the change only affects FDA-approved and state-regulated medical products. While the rescheduling is a step forward, Tilray still faces challenges and is not expected to see significant growth until full federal legalization. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/02a5b69472c97491
NOW PLAYING
Tilray's Rescheduling Hopes Dampened
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m